Mechanisms of infection by the human fungal pathogen Cryptococcus neoformans

Wilber Sabiiti1, Robin C May

  • 1Infection & Immunity, Clinical Sciences Division, St Georges' University of London, London SW17 0RE, UK.

Future Microbiology
|October 19, 2012
PubMed

Insights

Cryptococcus neoformans causes meningoencephalitis, a deadly brain infection. This review explores its pathogenesis, transmission to the brain, and potential new therapies for cryptococcosis.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Neuroscience

Background:

  • Cryptococcus neoformans causes meningoencephalitis, leading to high mortality.
  • Cryptococcal meningitis affects one million people globally, with over 60% mortality within 3 months.
  • Infection is acquired via inhalation, with initial colonization in the lungs.

Purpose of the Study:

  • To review the pathogenesis of C. neoformans from environmental exposure to brain dissemination.
  • To elucidate current understanding of cryptococcal transmission mechanisms into the brain.
  • To provide insights into future research and novel therapeutic strategies for cryptococcosis.

Main Methods:

  • Literature review of existing research on Cryptococcus neoformans pathogenesis and transmission.
  • Synthesis of current knowledge on the mechanisms of fungal entry into the central nervous system.
  • Analysis of emerging therapeutic approaches for cryptococcal infections.

Main Results:

  • C. neoformans infection initiates in the lungs, with potential for clearance, latency, or dissemination.
  • The brain is a preferential site for cryptococcal dissemination, resulting in meningoencephalitis.
  • Understanding transmission pathways is crucial for developing targeted interventions.

Conclusions:

  • Meningoencephalitis caused by C. neoformans remains a significant global health challenge.
  • Further research into fungal pathogenesis and host-pathogen interactions is essential.
  • Development of novel therapies is critical to improve outcomes for cryptococcal meningitis patients.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...